Doing our best: Surgery for rectal cancer

Gut

Volumn 57, Issue 12, 2008, Pages 1643-1645

  Bertagnolli, Monica M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CLINICAL TRIAL; HUMAN; LYMPHADENECTOMY; MEDICAL DECISION MAKING; NOTE; PRIORITY JOURNAL; QUALITY OF LIFE; RECTUM ABDOMINOPERINEAL RESECTION; RECTUM ANTERIOR RESECTION; RECTUM CANCER; TREATMENT OUTCOME;

ANAL CANAL; HUMANS; PROCTOSCOPY; QUALITY OF LIFE; RECTAL NEOPLASMS;

EID: 56549131006     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2008.158030     Document Type: Note

References (17)

1. Birbeck KF, Macklin CP, Tiffin NJ, et al. Rates of circumferential margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg 2002;235:449-57.
2. Den Dulk M, Van De Velde CJH. Quality assurance in surgical oncology: The tale of the Dutch Rectal Cancer TME Trial. J Surg Oncol 2008;97:5-7.
3. Wibe A, Syse A, Anderson E, et al. Oncological outcomes after total mesorectal excision for cure for cancer of the lower rectum: Anterior vs. abdominoperineal resection. Dis Colon Rectum 2004;47:48-58.
4. Marr R, Birbeck K, Garvican J, et al. The modern abdominoperineal excision: The next challenge after total mesorectal excision. Ann Surg 2005;242:74-82.
5. Nelson H, Petrelli N, Carlin A, et al. Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst 2001;93:583- 96.
6. Morris E, Quirk P, Thomas JD, et al. Unacceptable variation in abdominoperineal excision rates for rectal cancer: time to intervene? Gut 2008;57:1690-7.
7. Arbman G, Nilsson E, Hallbrook O, et al. Local recurrence following total mesorectal excision for rectal cancer. Br J Surg 1996;83:375-9.
8. Martling AL, Holm T, Rutqvist LE, et al. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Lancet 2000;356:93-6.
9. Peeters KC, Marijnen CAN, Nagtegaal ID, et al. The TME Trial after a median follow-up of 6 years: Increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 2007;246:693-701.
10. Association of Coloproctologists of Great Britain and Ireland. Guidelines for the management of colorectal cancer. London: Association of Coloproctologists of Great Britain & Ireland, 2007.
11. Byers TE, Wolf HJ, Bauer KR, et al. The impact of socioeconomic status on survival after cancer in the United States: findings from the National Program of Cancer Registries Patterns of Care Study. Cancer 2008;113:582-91.
12. McGroy ML, Zingmond DS, Sekeris E, et al. A patient's race/ethnicity does not explain the underuse of appropriate adjuvant therapy in colorectal cancer. Dis Colon Rectum 2006;49:319-29.
13. Lemmens VE, van Halteren AH, Janssen-Heijnen ML, et al. Adjuvant treatment for elderly patients with stage III colon cancer in the southern Netherlands is affected by socioeconomic status, gender, and comorbidity. Ann Oncol 2005;16:767-72.
14. Colorectal Cancer Collaborative Group. Adjuvant radiotherapy for rectal cancer: A systematic overview of 8,507 patients from 22 randomised trials. Lancet 2001;358:1291-304.
15. Glynne-Jones R, Harrison M. Locally advanced rectal cancer: What is the evidence for induction chemoradiation? The Oncologist 2007;12:1309-18.
16. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731-40.
17. Bujko K, Kepka L, Michalski W, et al. Does rectal cancer shrinkage induced by preoperative radio(chemo)therapy increase the likelihood of anterior resection? A systematic review of randomised trials. Radiother Oncol 2006;80:4-12.